AXGN
Ticker
Axogen
Company
Devices
Industry
Healthcare
Sector
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
58.6%42.3%53.6%62.5%50.4%47.0%38.9%27.1%5.2%13.4%8.8%14.7%17.8% 18.7%
Revenue Growth QoQ
Gross Margin
50.0%74.5%77.7%79.5%82.3%84.3%84.6%84.6%83.7%80.8%82.0%82.6%76.6%75.8% 74.8%
EBITDA Margin
-136.7%-97.3%-86.4%-57.1%-33.0%-18.7%-12.2%-23.4%-28.4%-19.2%-17.6%-19.2%-10.7%1.8% 5.1%
Operating Margin
-143.7%-101.4%-87.6%-58.3%-33.9%-19.8%-13.2%-24.4%-29.4%-20.6%-20.0%-21.4%-13.5%-1.8% 1.8%
Profit Margin
-190.1%-122.4%-133.0%-105.3%-48.9%-35.1%-17.3%-26.7%-27.3%-21.2%-21.2%-20.9%-13.7%-5.3% -1.0%
FCF / EBITDA
108.2%117.4%113.1%115.0%150.9%161.1%142.6%124.5%82.7%149.7%186.0%140.2%121.6%0.3% 18.9%